Kiniksa Pharmaceuticals Ltd. (KNSA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1247631,
    "name": "Kiniksa Pharmaceuticals Ltd.",
    "stock_name": "Kiniksa Pharmaceuticals Ltd.",
    "full_name": "Kiniksa Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/kiniksa-pharmaceuticals",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "42.00",
    "chg": 0.53,
    "chgp": "1.28%",
    "dir": 1,
    "prev_price": "41.47",
    "mcapval": "1,410.26",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "BMG5269C1010",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "245.45 k",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kiniksa-pharmaceuticals-1247631-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Kiniksa Pharmaceuticals Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kiniksa-pharmaceuticals-ltd-technically-bullish-or-bearish-3547727",
        "imagepath": "",
        "date": "2025-09-20 20:01:44",
        "description": "As of 26 August 2025, the technical trend for Kiniksa Pharmaceuticals Ltd. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and the moving averages are bullish on the daily time frame. Additionally, the KST and Dow Theory both indicate a bullish trend on weekly and monthly bases. Bollinger Bands show a mildly bullish signal weekly and bullish monthly. \n\nIn terms of performance, Kiniksa has significantly outperformed the S&P 500 year-to-date with a return of 81.60% compared to the S&P 500's 12.22%. Over the past year, Kiniksa has returned 42.14% against the S&P 500's 17.14%. Overall, the technical indicators suggest a strong bullish sentiment for Kiniksa Pharmaceuticals Ltd...."
      },
      {
        "title": "Is Kiniksa Pharmaceuticals Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kiniksa-pharmaceuticals-ltd-overvalued-or-undervalued-3544012",
        "imagepath": "",
        "date": "2025-09-20 18:35:08",
        "description": "As of 29 July 2025, the valuation grade for Kiniksa Pharmaceuticals Ltd. moved from risky to attractive, indicating a more favorable outlook. The company appears to be undervalued, particularly when considering its Price to Book Value of 2.78, EV to Sales ratio of 2.09, and a notably high P/E ratio of 294.42, which reflects its loss-making status but suggests potential for future growth. \n\nIn comparison with peers, Kiniksa's valuation metrics stand out, especially against Amneal Pharmaceuticals, which has a P/E of 48.88, and NewAmsterdam Pharma, which shows a negative P/E. Despite recent stock performance showing a decline of 2.95% over the past week compared to a 1.05% increase in the S&P 500, Kiniksa has demonstrated strong returns year-to-date at 81.60%, significantly outperforming the S&P 500's 12.22%. This combination of metrics and performance suggests that Kiniksa Pharmaceuticals Ltd. may be a compel..."
      }
    ],
    "total": 7,
    "sid": "1247631",
    "stock_news_url": "https://www.marketsmojo.com/news/kiniksa-pharmaceuticals-1247631"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Kiniksa Pharmaceuticals Ltd. technically bullish or bearish?

2025-09-20 20:01:44

As of 26 August 2025, the technical trend for Kiniksa Pharmaceuticals Ltd. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and the moving averages are bullish on the daily time frame. Additionally, the KST and Dow Theory both indicate a bullish trend on weekly and monthly bases. Bollinger Bands show a mildly bullish signal weekly and bullish monthly. In terms of performance, Kiniksa has significantly outperformed the S&P 500 year-to-date with a return of 81.60% compared to the S&P 500's 12.22%. Over the past year, Kiniksa has returned 42.14% against the S&P 500's 17.14%. Overall, the technical indicators suggest a strong bullish sentiment for Kiniksa Pharmaceuticals Ltd....

Is Kiniksa Pharmaceuticals Ltd. overvalued or undervalued?

2025-09-20 18:35:08

As of 29 July 2025, the valuation grade for Kiniksa Pharmaceuticals Ltd. moved from risky to attractive, indicating a more favorable outlook. The company appears to be undervalued, particularly when considering its Price to Book Value of 2.78, EV to Sales ratio of 2.09, and a notably high P/E ratio of 294.42, which reflects its loss-making status but suggests potential for future growth. In comparison with peers, Kiniksa's valuation metrics stand out, especially against Amneal Pharmaceuticals, which has a P/E of 48.88, and NewAmsterdam Pharma, which shows a negative P/E. Despite recent stock performance showing a decline of 2.95% over the past week compared to a 1.05% increase in the S&P 500, Kiniksa has demonstrated strong returns year-to-date at 81.60%, significantly outperforming the S&P 500's 12.22%. This combination of metrics and performance suggests that Kiniksa Pharmaceuticals Ltd. may be a compel...

View All News